Total Payments
$6,783
2024 Payments
$770.94
Companies
30
Transactions
381
Medicare Patients
2,964
Medicare Billing
$407,713
Payment Breakdown by Category
Food & Beverage$6,683 (98.5%)
Education$100.59 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,683 | 379 | 98.5% |
| Education | $100.59 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $978.34 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $871.67 | 78 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $820.72 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $739.46 | 38 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $710.97 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $455.67 | 24 | $0 (2023) |
| Merck Sharp & Dohme LLC | $382.01 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $323.78 | 14 | $0 (2024) |
| PFIZER INC. | $185.51 | 11 | $0 (2024) |
| Boston Scientific Corporation | $160.50 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $770.94 | 39 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($193.30) |
| 2023 | $873.06 | 46 | CSL Behring ($165.99) |
| 2022 | $1,035 | 56 | Boston Scientific Corporation ($136.97) |
| 2021 | $1,196 | 83 | AstraZeneca Pharmaceuticals LP ($362.52) |
| 2020 | $687.13 | 47 | Janssen Pharmaceuticals, Inc ($198.66) |
| 2019 | $1,026 | 51 | Janssen Pharmaceuticals, Inc ($200.51) |
| 2018 | $638.92 | 27 | E.R. Squibb & Sons, L.L.C. ($187.10) |
| 2017 | $556.92 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($138.67) |
All Payment Transactions
381 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Immunology | ||||||
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Immunology | ||||||
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Structural Heart | ||||||
| 08/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.31 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: DIABETES | ||||||
| 06/20/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $23.83 | General |
| Category: Coronary | ||||||
| 06/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 730 | 1,700 | $262,646 | $100,225 |
| 2022 | 8 | 804 | 1,963 | $275,682 | $114,155 |
| 2021 | 8 | 704 | 1,535 | $221,870 | $96,806 |
| 2020 | 11 | 726 | 1,665 | $229,245 | $96,527 |
Total Patients
2,964
Total Services
6,863
Medicare Billing
$407,713
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 146 | 772 | $92,640 | $43,993 | 47.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 158 | 205 | $47,150 | $19,325 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 239 | $35,850 | $13,119 | 36.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 151 | 202 | $30,300 | $11,686 | 38.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 43 | 160 | $41,460 | $7,675 | 18.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 12 | 12 | $4,000 | $1,438 | 35.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 12 | 14 | $2,467 | $1,244 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $1,980 | $989.89 | 50.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 70 | 85 | $6,800 | $754.96 | 11.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 171 | 995 | $119,400 | $54,321 | 45.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 177 | 231 | $53,130 | $23,866 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 256 | $38,400 | $14,466 | 37.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 172 | 227 | $34,050 | $12,313 | 36.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 35 | 81 | $13,757 | $4,138 | 30.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 24 | 61 | $6,405 | $2,566 | 40.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $1,980 | $1,025 | 51.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 74 | 89 | $7,120 | $803.93 | 11.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $1,440 | $654.55 | 45.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 149 | 733 | $87,960 | $40,876 | 46.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 164 | 214 | $49,220 | $22,511 | 45.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 261 | $39,150 | $16,714 | 42.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 165 | 217 | $32,550 | $12,044 | 37.0% |
| 99235 | Hospital observation or inpatient care moderate severity, 50 minutes per day' | Facility | 2021 | 12 | 12 | $3,000 | $1,557 | 51.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $2,700 | $1,425 | 52.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 17 | 26 | $2,730 | $1,110 | 40.7% |
About Dr. Mohamed Sabbagh, MD
Dr. Mohamed Sabbagh, MD is a Family Medicine healthcare provider based in Weston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1124349493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Sabbagh, MD has received a total of $6,783 in payments from pharmaceutical and medical device companies, with $770.94 received in 2024. These payments were reported across 381 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,683).
As a Medicare-enrolled provider, Sabbagh has provided services to 2,964 Medicare beneficiaries, totaling 6,863 services with total Medicare billing of $407,713. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weston, WV
- Active Since 06/21/2010
- Last Updated 10/18/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124349493
Products in Payments
- Haegarda (Biological) $863.95
- XARELTO (Drug) $820.72
- ENTRESTO (Drug) $753.67
- LifeVest (Device) $710.97
- ELIQUIS (Drug) $610.16
- BRILINTA (Drug) $423.04
- JARDIANCE (Drug) $307.09
- VERQUVO (Drug) $306.71
- Vascepa (Drug) $135.75
- ENROUTE Transcarotid Neuroprotection System (Device) $126.73
- BREZTRI (Drug) $122.36
- LEQVIO (Drug) $118.00
- FFRct (Device) $115.50
- Humira (Biological) $115.34
- Kcentra (Biological) $114.39
- General - Angioplasty (Device) $114.10
- XIENCE SIERRA (Device) $112.62
- JANUVIA (Drug) $60.53
- PRALUENT ALIROCUMAB INJECTION (Biological) $56.88
- VRAYLAR (Drug) $56.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weston
Dr. Jeremy Williams, Md, MD
Family Medicine — Payments: $12,259
Family Medicine $12,259
Debra Keith, Do, DO
Family Medicine — Payments: $7,231
Family Medicine $7,231
Dr. Ava Rosenberg, D.o, D.O
Family Medicine — Payments: $4,015
Family Medicine $4,015
Dr. Ashleigh Keator, Do, DO
Family Medicine — Payments: $3,738
Family Medicine $3,738
Dr. Cindy Marika, D.o, D.O
Family Medicine — Payments: $3,501
Family Medicine $3,501
Dr. Yaneth Trujillo, Md, MD
Family Medicine — Payments: $3,481
Family Medicine $3,481